Upadacitinib CAS 1310726-60-3

Upadacitinib CAS 1310726-60-3

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 1310726-60-3 Name Upadacitinib Synonyms (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluorethyl)-1-pyrrolidincarboxamid [German] [ACD/IUPAC Name] (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide [ACD/IUPAC Name] (3S,4R)-3-Éthyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroéthyl)-1-pyrrolidinecarboxamide [French] [ACD/IUPAC Name] (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide 10209 1310726-60-3 [RN] 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)- [ACD/Index Name] 4RA0KN46E0 ABT-494 UNII:4RA0KN46E0 UNII-4RA0KN46E0 upadacitinib [INN] [USAN] upadacitinib [Spanish] [INN] upadacitinib [French] [INN] upadacitinibum [Latin] [INN] упадацитиниб [Russian] [INN]…

Eltrombopag CAS 496775-61-2

Eltrombopag CAS 496775-61-2

496775-61-2,Eltrombopag,Eltrombopag;3′-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylicacid;(1,1′-Biphenyl)-3-carboxylicacid,3′-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2′-hydroxy-;Eltrombopag[inn];Promacta;Sb497115;Sb-497115;Unii-S56D65xj9g

Cisatracuriumbesylate CAS 96946-42-8

Cisatracuriumbesylate CAS 96946-42-8

96946-42-8,Cisatracuriumbesylate,(1r,1’r,2r,2’r)-2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinoliniumdibenzenesulfonate;cisatracuriumbesilate;cisatracuriumbesylate;1R-CIS,1R¡Ä-CIS(CISATRACURIUMBESYLATE);Cisatracurium;CisatrcuriumBesylate;3-[(1R,2R)-6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propionicacid5-[3-[(1R,2R)-6,7-dimethoxy-2-methyl-1-veratryl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentylester;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate

Prasugrel CAS 150322-43-3

Prasugrel CAS 150322-43-3

150322-43-3,Prasugrel,Efient;Prasugrel;2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone;Ethanone,2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-C)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-;Ly640315;Ly640315;Ly-640315;Unii-34K66tbt99

Rivaroxaban CAS 366789-02-8

Rivaroxaban CAS 366789-02-8

366789-02-8,Rivaroxaban,(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABANSTAGE-IV[5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(ASPERINV;RivaroxabanIsomer;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY59-7939;Rivaroxaban;5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide

Lumacaftor(VX-809) CAS 936727-05-8

Lumacaftor(VX-809) CAS 936727-05-8

936727-05-8,Lumacaftor(VX-809),3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)be;VX-809(LuMacaftor);3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoicacidVX809Lumacaftor;3-(6-{[1-(2;LumacaftorVX809;VX809,;VX-809,Lumacaftor,VRT826809;3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]benzoicacid

Dapoxetinehydrochloride CAS 119356-77-3

Dapoxetinehydrochloride CAS 119356-77-3

119356-77-3,Dapoxetinehydrochloride,Dapoxetine-d7HCl;(S)-(+)-Dapoxetine;Dapoxetinehydrochloride(S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanaminehydrochloride;Detoxetine;(S)-(+)-N,N-dimethyl-a-(2-(naphthalenyloxy)ethyl)benzenemethanamine;DAPOXETIN;DAPOXETINE;(S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanaminehydrochloride

Brexpiprazole CAS 913611-97-9

Brexpiprazole CAS 913611-97-9

913611-97-9,Brexpiprazole,7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one;Brexpiprazole;OPC-34712;7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2(1H)-Quinolinone;7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one;7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one;Brexpiprazoleimpuritya